What can we learn from COVID-19 that could protect us from pandemic influenza? What fresh insights could speed development of next-generation influenza vaccines? The Influenzer Initiative explores these questions in publications ranging from a comprehensive white paper to topic-specific commentaries.
Seize the game-changing potential of mRNA vaccines
Promising mRNA vaccines years ago emerged from early-stage development, only to stall before proving themselves in clinical trials. Pushed by pandemic urgency across the notorious “Valley of Death,” this platform vastly exceeded expectations and is now poised to transform the vaccine R&D landscape. During the early months of the historic rollout of COVID-19 vaccines, we captured reflections by experts and innovators on the past, present and game-changing future of the mRNA platform.
Read our latest blog with the Global Health Technologies Coalition (GHTC) featuring insights from these conversations revealing the potential of mRNA vaccines to protect against future pandemic threats including influenza, as well as to facilitate equitable access to vaccines worldwide.